Table 1.

Sample demographics, motion during neuroimaging, and clinical characteristics

	Sample (n = 45)
	Mean (SD)
Depressive symptoms (CESD score)	19.9 (16.8)
Trait brooding rumination (RRSB score)	11.8 (4.8)
Age (years)	16.0 (1.6)
FMRI outlier volumes (as % of scan series)	3.3 (4.5)
	%
Gender
Female	71.1%
Male	24.5%
Non-binary	4.4%
Medication use
Norepinephrine-dopamine reuptake inhibitor	13.3%
Selective serotonin-norepinephrine reuptake inhibitor	8.9%
Selective serotonin reuptake inhibitor	40.0%
Tetracyclics	2.2%
Anticonvulsants/Antipsychotics	17.8%
Lithium	6.7%
Anxiolytics (non-Benzodiazepine)	8.9%
Race
White	77.8%
African American	2.2%
Asian	8.9%
American Indian/Alaskan Native	0.0%
Hawaiian/Pacific Islander	0.0%
Biracial or other	11.1%
Ethnicity
Hispanic	4.4%
Not Hispanic or other	95.6%
	% Current diagnosis
Major depressive disorder (MDD)	51.1%
Anxiety disorders secondary to MDD	15.6%
Posttraumatic stress disorder	0.0%
Generalized anxiety disorder	15.6%
Panic disorder	4.4%
Agoraphobia	0.0%
Social phobia	2.2%
Specific phobia	0.0%
(Mild) substance use disorders	0.0%

CESD Center for Epidemiological Studies Depression Scale, MDD major depressive disorder, SD standard deviation